We are live on ! Find out more
ALIM

Alimera Sciences
ALIM

Delisted

ALIM was delisted on the 13th of September, 2024.

Back to rankings

19 hedge funds and large institutions have $7.02M invested in Alimera Sciences in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

53% more capital invested

Capital invested by funds: $4.59M → $7.02M (+$2.43M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

10% less funds holding

Funds holding: 21 → 19 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
19
Holders Change
-2
Holders Change %
-9.52%
% of All Funds
0.39%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
4
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$58K
2
DMK
David M. Knott
+$26.1K
3
TRCT
Tower Research Capital (TRC)
New York
+$4.89K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.87K
5
Bank of America
Bank of America
North Carolina
+$371

Top Sellers

Rank Fund Capital Flow
1
RA
Royce & Associates
New York
-$235K
2
Morgan Stanley
Morgan Stanley
New York
-$30.4K
3
Deutsche Bank
Deutsche Bank
Germany
-$11K
4
Victory Capital Management
Victory Capital Management
Texas
-$6K
5
BlackRock
BlackRock
New York
-$1.62K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACA
1
Avoro Capital Advisors
New York
$2.62M – – –
PAI
2
Palo Alto Investors
California
$1.27M – – –
WVP
3
Worth Venture Partners
New Jersey
$802K – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$746K – – –
Renaissance Technologies
5
Renaissance Technologies
New York
$549K +$58K +11,100 +15%
DMK
6
David M. Knott
$505K +$26.1K +5,000 +7%
JAM
7
JW Asset Management
Florida
$174K – – –
BCM
8
Bridgeway Capital Management
Texas
$164K – – –
Geode Capital Management
9
Geode Capital Management
Massachusetts
$87K +$2.87K +549 +4%
BlackRock
10
BlackRock
New York
$64K -$1.62K -310 -3%
Morgan Stanley
11
Morgan Stanley
New York
$30K -$30.4K -5,827 -55%
TRCT
12
Tower Research Capital (TRC)
New York
$10K +$4.89K +936 +176%
AA
13
Ancora Advisors
Ohio
$2K – – –
RA
14
Royce & Associates
New York
– -$235K -61,125 Closed
Deutsche Bank
15
Deutsche Bank
Germany
– -$11K -2,666 Closed
Victory Capital Management
16
Victory Capital Management
Texas
– -$6K -1,274 Closed
Bank of America
17
Bank of America
North Carolina
– +$371 +71 New

ALIM Hedge Fund Activity: Q2 2020 in Review

19 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q2 2020, worth a combined $7.02M — up 53% from $4.59M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of ALIM and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 4 added.

The largest buyer was Renaissance Technologies, adding an estimated $58K. The largest seller was Royce & Associates, exiting entirely with an estimated $235K sold.

  • 19 institutional investors held Alimera Sciences (ALIM) as of Q2 2020, down from 21 in Q1 2020.
  • Funds reported $7.02M of Alimera Sciences stock for Q2 2020, up 53% quarter-over-quarter.
  • 1 fund opened new Alimera Sciences positions in Q2 2020 and 3 closed out, a net change of -2 holders.
  • The largest Alimera Sciences buyer in Q2 2020 was Renaissance Technologies, an estimated $58K added.
  • The largest Alimera Sciences seller in Q2 2020 was Royce & Associates, an estimated $235K sold.

Based on aggregated 13F filings for Q2 2020.